A critical scientific evaluation of a purportedly negative data report - response to Seneviratne et al. 2022
- PMID: 37860166
- PMCID: PMC10582924
- DOI: 10.3389/fpsyt.2023.1271229
A critical scientific evaluation of a purportedly negative data report - response to Seneviratne et al. 2022
Abstract
A core principle in the pursuit of scientific knowledge is that science is self-correcting and that important results should be replicable. Hypotheses need to be reinforced, adjusted, or rejected when novel results are obtained. Replication of results confirms hypotheses and enhances their integration into scientific practice. In contrast, publication of substantiated and replicated negative findings (i.e., non-significant or opposite findings) can be the basis to reject erroneous hypotheses or develop alternative strategies for investigation. Replication is a problem in all research fields. The Psychology Reproductivity Project reported that only 36% of 'highly influential' published research in highly ranked journals were reproduced. Similar to positive data, negative data can be flawed. Errors in a negative data set can be based on methodology, statistics, conceptual defects, and flawed peer review. The peer review process has received progressive scrutiny. A large-scale review of the peer review process of manuscripts submitted to the British Medical Journal group indicated that the process could be characterized as inconsistent, inaccurate, and biased. Further analysis indicated that the peer process is easily manipulated, indicative of a failed system, is a major factor behind the lack of replication in science (acceptance of flawed manuscripts), suppresses opposing scientific evidence and views, and causes gaps in and lack of growth of science. Complicating the integrity of scientific publication is the role of Editors/Researchers. Ethical guidelines exist for major publishing houses about editorial ethics, behavior, and practice.
Keywords: 5HT-3 receptor; alcohol treatment; ethics; false negative; genotype; ondansetron; precision medicine; serotonin.
Copyright © 2023 Johnson, Addolorato, Lesch, Liu and Rodd.
Conflict of interest statement
BJ is the CMO and Founder of Adial Pharmaceuticals, LL is an independent statistical contributor but consults for Adial Pharmaceuticals, ZR is an employee of Adial Pharmaceuticals at the time of manuscript completion. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Views of Iranian medical journal editors on medical research publication.Saudi Med J. 2004 Jan;25(1 Suppl):S29-33. Saudi Med J. 2004. PMID: 14968189
-
Analysis of the Revision Process by American Journal of Roentgenology Reviewers and Section Editors: Metrics of Rejected Manuscripts and Their Final Disposition.AJR Am J Roentgenol. 2017 Jun;208(6):1181-1184. doi: 10.2214/AJR.16.17631. Epub 2017 Mar 28. AJR Am J Roentgenol. 2017. PMID: 28350482
-
Acceptance rates for manuscripts submitted to veterinary peer-reviewed journals in 2012.Equine Vet J. 2015 Nov;47(6):736-40. doi: 10.1111/evj.12376. Epub 2014 Dec 18. Equine Vet J. 2015. PMID: 25302854
-
Peer review in medical journals: Beyond quality of reports towards transparency and public scrutiny of the process.Eur J Intern Med. 2016 Jun;31:15-9. doi: 10.1016/j.ejim.2016.04.014. Epub 2016 Apr 26. Eur J Intern Med. 2016. PMID: 27129625 Review.
-
Statement on Publication Ethics for Editors and Publishers.J Korean Med Sci. 2016 Sep;31(9):1351-4. doi: 10.3346/jkms.2016.31.9.1351. J Korean Med Sci. 2016. PMID: 27510376 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources